Toripalimab (anti-PD-1) versus high-dose interferon-α2b as adjuvant therapy in resected mucosal melanoma: a phase II randomized trial
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference26 articles.
1. Incidence of noncutaneous melanomas in the;McLaughlin;U.S. Cancer,2005
2. The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients;Lian;Ann Oncol,2017
3. Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases;Chi;BMC Cancer,2011
4. Multifactorial analysis of prognostic factors and survival rates among 706 mucosal melanoma patients;Cui;Ann Surg Oncol,2018
5. Phase II randomized trial comparing high-dose IFN-alpha2b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma;Lian;Clin Cancer Res,2013
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy;European Journal of Cancer;2024-03
2. Immunotherapy for mucosal melanoma;Oncology and Translational Medicine;2023-12
3. Risk and Incidence of Endocrine Immune-Related Adverse Effects Under Checkpoint Inhibitor Mono- or Combination Therapy in Solid Tumors: A Meta-Analysis of Randomized Controlled Trials;The Journal of Clinical Endocrinology & Metabolism;2023-11-15
4. Phase II clinical trial of neoadjuvant anti-PD-1 (toripalimab) combined with axitinib in resectable mucosal melanoma;Annals of Oncology;2023-11
5. A human mucosal melanoma organoid platform for modeling tumor heterogeneity and exploring immunotherapy combination options;Science Advances;2023-10-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3